cyplasin glycoprotein (Cyplasin Biomedical)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namecyplasin glycoprotein (Cyplasin Biomedical)
Drug Alias NameCyplasin-SC
ClassificationBiologics > Protein drugs > Recombinant proteinNatural product/Extract
Mechanisms of ActionApoptosis stimulants
TargetsUpdating
Therapy Area/IndicationsSkin NeoplasmsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCompass Biotechnologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCompass Biotechnologies Inc
Active IndicationsN/A
Inactive IndicationsSkin NeoplasmsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A